107 related articles for article (PubMed ID: 23725108)
1. Power and promise of ubiquitin carboxyl-terminal hydrolase 37 as a target of cancer therapy.
Chen YJ; Ma YS; Fang Y; Wang Y; Fu D; Shen XZ
Asian Pac J Cancer Prev; 2013; 14(4):2173-9. PubMed ID: 23725108
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications.
Fang Y; Shen X
Cancer Metastasis Rev; 2017 Dec; 36(4):669-682. PubMed ID: 29080080
[TBL] [Abstract][Full Text] [Related]
3. Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1.
Yao T; Song L; Xu W; DeMartino GN; Florens L; Swanson SK; Washburn MP; Conaway RC; Conaway JW; Cohen RE
Nat Cell Biol; 2006 Sep; 8(9):994-1002. PubMed ID: 16906146
[TBL] [Abstract][Full Text] [Related]
4. Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets.
Lu X; Nowicka U; Sridharan V; Liu F; Randles L; Hymel D; Dyba M; Tarasov SG; Tarasova NI; Zhao XZ; Hamazaki J; Murata S; Burke TR; Walters KJ
Nat Commun; 2017 Jun; 8():15540. PubMed ID: 28598414
[TBL] [Abstract][Full Text] [Related]
5. Isolation and Characterization of RNA Aptamers against a Proteasome-Associated Deubiquitylating Enzyme UCH37.
Lee JH; Lee MJ
Chembiochem; 2017 Jan; 18(2):171-175. PubMed ID: 27930845
[TBL] [Abstract][Full Text] [Related]
6. A fluorescence polarization-based competition assay for measuring interactions between unlabeled ubiquitin chains and UCH37•RPN13.
Du J; Strieter ER
Anal Biochem; 2018 Jun; 550():84-89. PubMed ID: 29698671
[TBL] [Abstract][Full Text] [Related]
7. Proteasome-Bound UCH37/UCHL5 Debranches Ubiquitin Chains to Promote Degradation.
Deol KK; Crowe SO; Du J; Bisbee HA; Guenette RG; Strieter ER
Mol Cell; 2020 Dec; 80(5):796-809.e9. PubMed ID: 33156996
[TBL] [Abstract][Full Text] [Related]
8. Regulation of NF-kappaB activity and inducible nitric oxide synthase by regulatory particle non-ATPase subunit 13 (Rpn13).
Mazumdar T; Gorgun FM; Sha Y; Tyryshkin A; Zeng S; Hartmann-Petersen R; Jørgensen JP; Hendil KB; Eissa NT
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13854-9. PubMed ID: 20634424
[TBL] [Abstract][Full Text] [Related]
9. The potential role of ubiquitin c-terminal hydrolases in oncogenesis.
Fang Y; Fu D; Shen XZ
Biochim Biophys Acta; 2010 Aug; 1806(1):1-6. PubMed ID: 20302916
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin carboxyl-terminal hydrolase isozyme L5 inhibits human glioma cell migration and invasion via downregulating SNRPF.
Ge J; Hu W; Zhou H; Yu J; Sun C; Chen W
Oncotarget; 2017 Dec; 8(69):113635-113649. PubMed ID: 29371935
[TBL] [Abstract][Full Text] [Related]
11. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.
Qiu XB; Ouyang SY; Li CJ; Miao S; Wang L; Goldberg AL
EMBO J; 2006 Dec; 25(24):5742-53. PubMed ID: 17139257
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19.
Fang Y; Fu D; Tang W; Cai Y; Ma D; Wang H; Xue R; Liu T; Huang X; Dong L; Wu H; Shen X
Biochim Biophys Acta; 2013 Mar; 1833(3):559-72. PubMed ID: 23220010
[TBL] [Abstract][Full Text] [Related]
13. Effect of ubiquitin carboxy-terminal hydrolase 37 on apoptotic in A549 cells.
Chen Z; Niu X; Li Z; Yu Y; Ye X; Lu S; Chen Z
Cell Biochem Funct; 2011 Mar; 29(2):142-8. PubMed ID: 21287580
[TBL] [Abstract][Full Text] [Related]
14. A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes.
Hamazaki J; Iemura S; Natsume T; Yashiroda H; Tanaka K; Murata S
EMBO J; 2006 Oct; 25(19):4524-36. PubMed ID: 16990800
[TBL] [Abstract][Full Text] [Related]
15. Proteasomal deubiquitinase UCH37 inhibits degradation of β-catenin and promotes cell proliferation and motility.
Li Z; Zhou L; Jiang T; Fan L; Liu X; Qiu X
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):277-284. PubMed ID: 30726867
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis.
Nan L; Jacko AM; Tan J; Wang D; Zhao J; Kass DJ; Ma H; Zhao Y
Sci Rep; 2016 Sep; 6():33116. PubMed ID: 27604640
[TBL] [Abstract][Full Text] [Related]
17. The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression.
Randles L; Anchoori RK; Roden RB; Walters KJ
J Biol Chem; 2016 Apr; 291(16):8773-83. PubMed ID: 26907685
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the Rpn13-induced activation of Uch37.
Jiao L; Ouyang S; Shaw N; Song G; Feng Y; Niu F; Qiu W; Zhu H; Hung LW; Zuo X; Eleonora Shtykova V; Zhu P; Dong YH; Xu R; Liu ZJ
Protein Cell; 2014; 5(8):616-30. PubMed ID: 24752541
[TBL] [Abstract][Full Text] [Related]
19. Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma.
Arpalahti L; Saukkonen K; Hagström J; Mustonen H; Seppänen H; Haglund C; Holmberg CI
Tumour Biol; 2017 Jun; 39(6):1010428317710411. PubMed ID: 28653876
[TBL] [Abstract][Full Text] [Related]
20. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling.
Wicks SJ; Haros K; Maillard M; Song L; Cohen RE; Dijke PT; Chantry A
Oncogene; 2005 Dec; 24(54):8080-4. PubMed ID: 16027725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
